Immunotherapy (Toripalimab) for Reducing Recurrence Risk After Surgery for Mismatch Repair Deficient Stage IIB, IIC, or III Colon Cancer

Clinical trial NCT07140679 · RECRUITING

Trial details

NCT number: NCT07140679
Sponsor: Emory University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Localized Colon Carcinoma Stage IIB Colon Cancer AJCC v8 Stage IIC Colon Cancer AJCC v8 Stage III Colon Cancer AJCC v8

Start date: 2025-09-19
Primary completion: 2029-09-30
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.